TY - JOUR
T1 - Reversibility of Unawareness of Hypoglycemia in Patients with Insulinomas
AU - Mitrakou, A.
AU - Fanelli, C.
AU - Veneman, T.
AU - Perriello, G.
AU - Calderone, S.
AU - Platanisiotis, D.
AU - Rambotti, A.
AU - Raptis, S.
AU - Brunetti, P.
AU - Cryer, P.
AU - Gerich, J.
AU - Bolli, G.
PY - 1993/9/16
Y1 - 1993/9/16
N2 - A lack of appropriate autonomic warning symptoms before the development of neuroglycopenia occurs frequently in patients with diabetes mellitus. The pathogenesis of this phenomenon is unclear, but it is associated with intensive insulin therapy, prolonged duration of diabetes, frequent episodes of hypoglycemia, and impaired glucose counterregulation. Recently, it has been proposed that repeated episodes of hypoglycemia may themselves induce the phenomenon. To test this hypothesis and to determine whether the phenomenon is reversible, we assessed autonomic and neuroglycopenic symptoms, counterregulatory hormonal responses, and cognitive function during stepped hypoglycemic-clamp studies in 6 patients with insulinomas before and approximately six months after curative surgery and in 14 normal subjects matched for age, weight, and sex. Before surgery, the patients with insulinomas had lower scores than the normal subjects for autonomic symptoms (mean [±SD], 3.5 ±0.8 vs. 9.6 ±4.5) and neuroglycopenic symptoms (2.8 ±1.5 vs. 8.9 ±5.3). The patients also had impaired counterregulatory hormonal responses (their plasma epinephrine, norepinephrine, glucagon, growth hormone, and cortisol responses before surgery were 187 ±227 pg per milliliter [1.03 ±1.25 nmol per liter], 223 ±85 pg per milliliter [1.32 ±0.50 nmol per liter], 86 ±21 ng per liter, 7.4 ±5.2 μg per liter, and 12.1 ±1.5 μg per deciliter [334 ±41 nmol per liter], respectively, as compared with 842 ±439 pg per milliliter [4.63 ±2.41 nmol per liter], 519 ±150 pg per milliliter [3.07 ±0.89 nmol per liter], 201 ±58 ng per liter, 25.3 ±13.7 μg per liter, and 26.3 ±1.2 μg per deciliter [726 ±33 nmol per liter] in the normal subjects) and less deterioration in cognitive function than the normal subjects during hypoglycemia (sum of z scores for seven tests of cognitive function, 1.7 ±1.9 vs. 8.9 ±3.5) (P<0.02 for all comparisons). Surgical cure reversed all these abnormalities (P not significant for all comparisons with the normal subjects). Hypoglycemia itself can induce unawareness of the autonomic and neuroglycopenic symptoms of hypoglycemia and decrease the counterregulatory hormonal responses to hypoglycemia., A lack of appropriate autonomic warning symptoms before the development of neuroglycopenia (unawareness of hypoglycemia) occurs frequently in patients with insulin-dependent (type I) diabetes mellitus1. Although the condition was first reported shortly after the introduction of insulin therapy,2 its pathogenesis remains unclear. It is associated with intensive insulin therapy,3–5 a prolonged duration of diabetes,6 impaired glucose counterregulation,3–5,7,8 and frequent episodes of hypoglycemia6,9. Because a decreased awareness of impending hypoglycemia can prevent patients from taking timely protective steps, this phenomenon can lead to more frequent and more severe episodes of hypoglycemia. It has been…
AB - A lack of appropriate autonomic warning symptoms before the development of neuroglycopenia occurs frequently in patients with diabetes mellitus. The pathogenesis of this phenomenon is unclear, but it is associated with intensive insulin therapy, prolonged duration of diabetes, frequent episodes of hypoglycemia, and impaired glucose counterregulation. Recently, it has been proposed that repeated episodes of hypoglycemia may themselves induce the phenomenon. To test this hypothesis and to determine whether the phenomenon is reversible, we assessed autonomic and neuroglycopenic symptoms, counterregulatory hormonal responses, and cognitive function during stepped hypoglycemic-clamp studies in 6 patients with insulinomas before and approximately six months after curative surgery and in 14 normal subjects matched for age, weight, and sex. Before surgery, the patients with insulinomas had lower scores than the normal subjects for autonomic symptoms (mean [±SD], 3.5 ±0.8 vs. 9.6 ±4.5) and neuroglycopenic symptoms (2.8 ±1.5 vs. 8.9 ±5.3). The patients also had impaired counterregulatory hormonal responses (their plasma epinephrine, norepinephrine, glucagon, growth hormone, and cortisol responses before surgery were 187 ±227 pg per milliliter [1.03 ±1.25 nmol per liter], 223 ±85 pg per milliliter [1.32 ±0.50 nmol per liter], 86 ±21 ng per liter, 7.4 ±5.2 μg per liter, and 12.1 ±1.5 μg per deciliter [334 ±41 nmol per liter], respectively, as compared with 842 ±439 pg per milliliter [4.63 ±2.41 nmol per liter], 519 ±150 pg per milliliter [3.07 ±0.89 nmol per liter], 201 ±58 ng per liter, 25.3 ±13.7 μg per liter, and 26.3 ±1.2 μg per deciliter [726 ±33 nmol per liter] in the normal subjects) and less deterioration in cognitive function than the normal subjects during hypoglycemia (sum of z scores for seven tests of cognitive function, 1.7 ±1.9 vs. 8.9 ±3.5) (P<0.02 for all comparisons). Surgical cure reversed all these abnormalities (P not significant for all comparisons with the normal subjects). Hypoglycemia itself can induce unawareness of the autonomic and neuroglycopenic symptoms of hypoglycemia and decrease the counterregulatory hormonal responses to hypoglycemia., A lack of appropriate autonomic warning symptoms before the development of neuroglycopenia (unawareness of hypoglycemia) occurs frequently in patients with insulin-dependent (type I) diabetes mellitus1. Although the condition was first reported shortly after the introduction of insulin therapy,2 its pathogenesis remains unclear. It is associated with intensive insulin therapy,3–5 a prolonged duration of diabetes,6 impaired glucose counterregulation,3–5,7,8 and frequent episodes of hypoglycemia6,9. Because a decreased awareness of impending hypoglycemia can prevent patients from taking timely protective steps, this phenomenon can lead to more frequent and more severe episodes of hypoglycemia. It has been…
UR - http://www.scopus.com/inward/record.url?scp=0027292271&partnerID=8YFLogxK
U2 - 10.1056/NEJM199309163291203
DO - 10.1056/NEJM199309163291203
M3 - Article
C2 - 8355741
AN - SCOPUS:0027292271
SN - 0028-4793
VL - 329
SP - 834
EP - 839
JO - New England Journal of Medicine
JF - New England Journal of Medicine
IS - 12
ER -